These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 825020)

  • 1. In vitro and in vivo evaluation of ceftezole, a new cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Sakamoto H; Fukada S; Nakamoto S; Yokota Y; Miki K
    Antimicrob Agents Chemother; 1976 Jul; 10(1):1-13. PubMed ID: 825020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftezole, a new cephalosporin C derivative II. Distribution and excretion in parenteral administration.
    Harada Y; Matsubara S; Kakimoto M; Noto T; Nehashi T
    J Antibiot (Tokyo); 1976 Oct; 29(10):1071-82. PubMed ID: 994326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity.
    Noto T; Nehashi T; Endo H; Saito M; Matsubara S
    J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evaluation of FR10612, a new oral cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Sakamoto H
    J Antibiot (Tokyo); 1976 Apr; 29(4):444-59. PubMed ID: 819411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory evaluation of FR10024 a new cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Fukada S
    Antimicrob Agents Chemother; 1977 Jan; 11(1):51-63. PubMed ID: 836014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F; Misiek M; Pursiano TA; Buck RE; Chisholm DR; DeRegis RG; Tsai YH; Price KE
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kondo M; Kita Y; Noji Y; Takeuchi M; Fugono T
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
    Actor P; Uri JV; Guarini JR; Zajac I; Phillips L; Sachs CS; DeMarinis RM; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Jun; 28(6):471-6. PubMed ID: 238925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 3: cephalosporins.
    Barza M; Miao PV
    Am J Hosp Pharm; 1977 Jun; 34(6):621-9. PubMed ID: 327800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.
    Harvengt C; Muenier H; Lamy F
    J Clin Pharmacol; 1977; 17(2-3):128-33. PubMed ID: 833342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic studies on ceftezole.
    Fraschini F; Scaglione F; De Pascale A; Del Mastro S
    Chemioterapia; 1986 Dec; 5(6):388-90. PubMed ID: 3802300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
    Miraglia GJ; Renz KJ; Gadebusch HH
    Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.